| Members |
targetComponentId |
| Hemolytic uremic syndrome |
Hemolytic uremic syndrome |
| Hemorrhage due to any device, implant AND/OR graft |
Bleeding |
| Hemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
| Hemorrhagic nephroso-nephritis |
Hemorrhagic fever with renal syndrome (disorder) |
| Hemorrhoidectomy by injection |
Destruction of hemorrhoids by sclerotherapy |
| Hemostasis of unspecified organ |
Control of hemorrhage |
| Hepadnavirus |
Family Hepadnaviridae (organism) |
| Heparin cofactor I |
Antithrombin III |
| Heparin sodium 100 unt/mL solution |
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection |
| Heparin sodium 1000iu/sodium chloride 0.9% infusion solution ampule |
Product containing only heparin in parenteral dose form (medicinal product form) |
| Heparin sodium 10u/mL injection solution ampule |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
| Heparin sodium 10unt/mL solution |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
| Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion |
Product containing only heparin in parenteral dose form (medicinal product form) |
| Hepatectomy |
Excision of liver (procedure) |
| Hepatic colic |
Biliary colic |
| Hepatitis |
Inflammatory disease of liver |
| Hepatitis B group virus |
Genus Orthohepadnavirus (organism) |
| poudre de 1000 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| poudre de 200 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| poudre de 500 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis B screening test |
Hepatitis B screening |
| flacon d'une solution injectable de 217 U d'immunoglobuline antihépatique B |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| flacon de 1 mL d'une solution injectable de 312 unités/mL d'immunoglobuline contre l'hépatite B |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
| flacon de 5 mL d'une solution injectable de 312 unités/mL d'immunoglobuline contre l'hépatite B |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
| hépatite à Toxoplasma |
Hepatitis caused by Toxoplasma gondii |
| Hepatitis non-A non-B |
Viral hepatitis |
| Hepatitis panel |
Hepatitis panel measurement |
| Hepatocerebral encephalopathy |
Hepatic encephalopathy |
| Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
| Hereditary disease |
Hereditary disease |
| Hereditary endotheliopathy, retinopathy, nephropathy, stroke syndrome |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| Hereditary methemoglobinemia, enzymatic type |
Autosomal recessive congenital methemoglobinemia (disorder) |
| Hereditary nonspherocytic hemolytic anemia due to aldolase A deficiency |
Glycogen storage disease due to aldolase A deficiency (disorder) |
| Hereditary nonspherocytic hemolytic anemia due to reduced nicotinamide adenine dinucleotide-methemoglobin reductase deficiency |
Autosomal recessive congenital methemoglobinemia (disorder) |
| Hereditary progressive muscular dystrophy |
Muscular dystrophy |
| Hereditary sensory-motor neuropathy, type V |
Hereditary motor and sensory neuropathy type 5 (disorder) |
| Hereditary thrombocytopenia NEC |
Hereditary thrombocytopenic disorder (disorder) |
| rétinopathie vasculaire héréditaire |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
| Hermaphroditism |
Ovotesticular disorder of sex development |
| hermaphrodisme |
Ovotesticular disorder of sex development |
| Heroin - non-pharmaceutical |
Diamorphine (substance) |
| Herpailurus yaguarondi |
Puma yagouaroundi (organism) |
| Herpes simplex with other specified complications |
Herpes simplex with complication |
| Herpes simplex with unspecified complications |
Herpes simplex with complication |
| zona avec complication ophtalmique |
Herpes zoster ophthalmicus |
| Herpes zoster with other complications |
Herpes zoster with complication |
| Herpes zoster with other nervous system complications |
Herpes zoster with nervous system complication |
| Herpes zoster with other ophthalmic complication |
Herpes zoster ophthalmicus |
| Herring - dietary |
Herring (substance) |
| Hetastarch 6% |
Hetastarch 60 mg/mL solution for injection |
| hetastarch 6% infusion solution bottle |
Hetastarch 60 mg/mL solution for injection |
| Hetastarch 6g liquid |
Hetastarch 60 mg/mL solution for injection |
| Hetastarch allergy |
Non-allergic hypersensitivity to hetastarch (finding) |
| Heteropagus |
Asymmetrical conjoined twins (disorder) |
| Hexahydrophtalic anhydrid specific extract |
Hexahydrophthalic anhydride (substance) |
| Hexamethylene diisocyanate specific extract |
Hexamethylene diisocyanate (substance) |
| hexastarch 6% infusion solution bottle |
Product containing precisely hexastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Hexosyltransferase |
Hexosyltransferase |
| Hickman catheter, device |
Central venous catheter |
| Hickman line injection |
Central venous catheter injection |
| Hickman line tip |
Central venous catheter tip |
| High risk non proliferative diabetic retinopathy |
Severe nonproliferative retinopathy due to diabetes mellitus (disorder) |
| High risk of |
High risk of |
| Hind brain contusion with open intracranial wound, unspecified state of consciousness |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hind brain contusion with open intracranial wound, with concussion, unspecified |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hind brain contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip enthesopathy NOS |
Enthesopathy of hip region |
| Hip enthesopathy, unspecified |
Enthesopathy of hip region |
| Hip fracture probability score using World Health Organization fracture risk assessment tool |
Hip fracture probability score using fracture risk assessment tool (observable entity) |
| Hip somatic dysfunction |
Somatic dysfunction of hip region (finding) |
| Hirundo fulva |
Petrochelidon fulva (organism) |
| Hirundo pyrrhonota |
Cliff swallow |
| Histamine phosphate 275mcg/mL injection solution ampule |
Histamine only product in parenteral dose form |
| Histiocytic proliferation - category |
Histiocytic proliferation (morphologic abnormality) |
| Histiocytoid hemangioma |
Epithelioid hemangioma |
| Histological grade |
Histologic grade (property) |
| Histological type |
Histologic type (property) (qualifier value) |
| anamnèse et examen physique, diagnostic |
History AND physical examination |
| History of - angiotensin converting enzyme inhibitor allergy |
H/O: angiotensin converting enzyme inhibitor pseudoallergy |
| History of analgesic allergy |
Allergy to drug |
| History of anesthetic allergy |
Allergy to drug |
| antécédents : allergie aux chats |
Allergy to Felis catus protein (finding) |
| antécédent de toxicomanie |
History of substance dependency (situation) |
| History of handicap in child of subject |
Child of subject has disability (situation) |
| Antécédents de tabagisme |
Ex-tobacco user |
| Hodgkin granuloma [obs] |
Hodgkin granuloma |
| Hodgkin lymphoma - category |
Hodgkin lymphoma |
| lymphome hodgkinien sans sous-type CIM-O (classification internationale des maladies - oncologie) |
Hodgkin lymphoma |
| Hodgkin sarcoma [obs] |
Hodgkin sarcoma (morphologic abnormality) |
| Hodgkin's disease of extranodal AND/OR solid organ site |
Hodgkin's disease (clinical) |
| Hodgkin's disease of lymph nodes of axilla AND/OR upper limb |
Hodgkin disease of lymph nodes of upper limb (disorder) |
| Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb |
Hodgkin disease of lymph nodes of lower limb (disorder) |
| Hodgkin's disease, lymphocytic depletion of extranodal AND/OR solid organ site |
Hodgkin's disease, lymphocytic depletion (clinical) |
| Hodgkin's disease, lymphocytic depletion of lymph nodes of axilla AND/OR upper limb |
Hodgkin disease, lymphocytic depletion of lymph nodes of upper limb (disorder) |
| Hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and upper limb |
Hodgkin disease, lymphocytic depletion of lymph nodes of upper limb (disorder) |
FHIR